Bringing Confidence to your Prostate Cancer Treatment Decisions
A revolutionary platform that delivers tailored insights for prostate cancer management, paving the way for personalized care and enhanced treatment outcomes.
Prostate Cancer Diagnosis and Treatment is Hard to Navigate
Treating the entire prostate, without Unfold AI, leads to urinary and sexual dysfunction in more than 50% of patients. [1]
Treating prostate cancer focally, without Unfold AI leads to 24-49% of patients having residual cancer. [2]
Patients treated with Unfold AI margins are 71% more likely to be cancer-free.[3]
Doctors Need to Know Where the Cancer is to Select the Correct Treatment Option, Preserve Quality of Life and Avoid Leaving Cancer Behind.
[1] Cooperberg MR et al. BJU Int. 2013;111:437-450. doi: 10.1111/j.1464-410X.2012.11597.x
[2] Ahdoot, Michaela; Lebastchi, Amir H.a; Turkbey, Barisb; Wood, Bradfordc; Pinto, Peter A.a. Contemporary treatments in prostate cancer focal therapy. Current Opinion in Oncology 31(3):p 200-206, May 2019. | DOI: 10.1097/CCO.0000000000000515
[3] Mota, Sakina Mohammed, et al. “Artificial Intelligence Improves the Ability of Physicians to Identify Prostate Cancer Extent.” 2024. Journal of Urology, vol. 212, no. 1, WoltersKluwer, July 2024, pp. 52–62, doi:10.1097/JU.0000000000003960.
[4] Priester, Alan et al. “Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology.” The Journal of urology vol. 197,2 (2017): 320-326. doi:10.1016/j.juro.2016.07.084
Learn more about Unfold AI
Include Unfold AI in your Treatment Journey
Click to:
Share this document with your doctor to inform them about Unfold AI.
How would you like to share this document?
Patients should not have to choose between treating their prostate cancer and maintaining their quality of life.
